<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rsp</journal-id><journal-title-group><journal-title xml:lang="ru">Научно-практическая ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Rheumatology Science and Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-4484</issn><issn pub-type="epub">1995-4492</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1995-4484-2014-300-303</article-id><article-id custom-type="elpub" pub-id-type="custom">rsp-1944</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Качество жизни больных подагрой мужчин: есть ли отличия от популяции? Результаты сравнительного исследования</article-title><trans-title-group xml:lang="en"><trans-title>QUALITY OF LIFE OF MALE GOUTY PATIENTS: ARE THERE DIFFERENCES FROM THE POPULATION? RESULTS OF A COMPARATIVE STUDY</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мукагова</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Mukagova</surname><given-names>M. V.</given-names></name></name-alternatives><email xlink:type="simple">maya_mukagova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Барскова</surname><given-names>В. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Barskova</surname><given-names>V. G.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Елисеев</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Eliseev</surname><given-names>M. S.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Научно- исследовательский институт ревматологии им. В.А. Насоновой» РАН, Москва, Россия</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Nasonova Research Institute of Rheumatology, Moscow, Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>23</day><month>06</month><year>2014</year></pub-date><volume>52</volume><issue>3</issue><issue-title>№3 (2014)</issue-title><fpage>300</fpage><lpage>303</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мукагова М.В., Барскова В.Г., Елисеев М.С., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Мукагова М.В., Барскова В.Г., Елисеев М.С.</copyright-holder><copyright-holder xml:lang="en">Mukagova M.V., Barskova V.G., Eliseev M.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://rsp.mediar-press.net/rsp/article/view/1944">https://rsp.mediar-press.net/rsp/article/view/1944</self-uri><abstract><p>Цель – оценить качество жизни (КЖ) больных подагрой мужчин на основании данных опросника SF-36 в сравнении со стандартизованными показателями популяционного контроля. Материал и методы. В исследование включено 153 больных подагрой мужчин, в каждом случае диагноз был подтвержден выявлением кристаллов моноурата натрия. Средний возраст пациентов составил 47,5±12,9 года (от 25 до 74 лет), медиана заболевания – 5,6 [3,03; 9,7] года. Проведено сравнение КЖ больных со стандар- тизованными показателями российской популяции с использованием опросника SF-36v1. Отдельно прово- дилось сравнение в разных возрастных группах: 25–34 года (n=23), 35–44 года (n=48), 45–54 года (n=44), 55–64 года (n=20), 65–74 года (n=18). Результаты. Суммарный физический компонент здоровья у больных подагрой (39,8±9,1) был ниже (p&lt;0,00001), а суммарный психологический компонент здоровья (51,72±8,3) не отличался от такового в по- пуляции. Наиболее существенные различия были выявлены по 4 шкалам, отражающим физический компо- нент здоровья. У больных подагрой отмечались достоверно большие, чем в контроле, показатели шкал: фи- зического функционирования (46,1±10,03 и 51,75±9,71; р&lt;0,0001), ролевого физического функционирова- ния (46,7±9,9 и 51,56±9,92; р&lt;0,0001), интенсивности боли (45,41±10,11 и 51,64±10,20; р&lt;0,0001) и общего состояния здоровья (47,73±9,6 и 51,47±10,15; р&lt;0,0001 соответственно). Также статистически значимы были различия по шкале жизнеспособности (р=0,0006) и шкале социального функционирования (р=0,020). Пока- затели психологического здоровья и ролевого эмоционального функционирования у больных подагрой муж- чин не отличались от популяционного контроля. Аналогичные представленным выше различия были выяв- лены и при проведении сравнительного анализа в разных возрастных группах. Заключение. У больных подагрой страдает преимущественно физическое здоровье, в меньшей мере – психо- логическое состояние, снижена социальная адаптация. </p></abstract><trans-abstract xml:lang="en"><p>Objective: to assess quality of life of male gouty patients with SF-36 questionnaire versus the standardized indicators of population-based control. Subjects and methods. The study included 153 male patients with gout, in each case the diagnosis was verified by detection of monosodium urate crystals. The patients' mean age was 47.5±12.9 years (25 to 74 years); the median dis- ease duration was 5.6 [3.03; 9.7] years. The SF-36v1 questionnaire was used to compare the quality of life of the patients with the standardized indicators of the Russian population. The comparison was made separately in different age groups: 25–34 years (n=23), 35–44 years (n=48), 45–54 years (n=44), 55–64 years (n=20), 65–74 years (n=18). Results. In the gouty patients, the physical health component summary score was lower (39.8±9.1; p &lt; 0.00001) and the mental health component summary score (51.72±8.3) did not differ from that in the population. The greatest dif- ferences were revealed in 4 scales reflecting the physical health component. The gouty patients versus the controls were found to have significantly higher scores of physical functioning (46.1±10.03 and 51.75±9.71; p &lt; 0.0001), role physical functioning (46.7±9.9 and 51.56±9.92; p &lt; 0.0001), pain intensity (45.41±10.11 and 51.64±10.20; p &lt; 0.0001), and general health condition (47.73±9.6 and 51.47±10.15; p &lt; 0.0001, respectively). Of statistical signifi- cance were also differences in the scales of vital capacity (p = 0.0006) and social functioning (p = 0.020). In the male gouty patients, the mental health and role emotional functioning scores were similar to the population-based control ones. Comparative analysis revealed the above-mentioned similar differences in different age groups. Conclusion. The physical health of the gouty patients is mainly poor and their mental health is poor to a lesser degree; their social adaptation is decreased. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>подагра</kwd><kwd>качество жизни</kwd><kwd>SF-36.</kwd></kwd-group><kwd-group xml:lang="en"><kwd>gout</kwd><kwd>quality of life</kwd><kwd>SF-36.</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Насонова ВА, Барскова ВГ. Ранние диагностика и лечение подагры – научно обоснованное требование улучшения тру- дового и жизненного прогноза больных. Научно-практиче- ская ревматология. 2004;44(1):5–7. [Nasonova VA, Barskova VG. Early diagnostics and gout treatment – scientifically reasonable requirement of improvement of the labor and vital forecast of patients. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2004;44(1):5–7. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Насонова ВА, Барскова ВГ. Ранние диагностика и лечение подагры – научно обоснованное требование улучшения тру- дового и жизненного прогноза больных. Научно-практиче- ская ревматология. 2004;44(1):5–7. [Nasonova VA, Barskova VG. Early diagnostics and gout treatment – scientifically reasonable requirement of improvement of the labor and vital forecast of patients. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2004;44(1):5–7. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Roddy E, Doherty M. Epidemiology of gout. Arthritis Res Ther. 2010;12(6):223. DOI: 10.1186/ar3199.</mixed-citation><mixed-citation xml:lang="en">Roddy E, Doherty M. Epidemiology of gout. Arthritis Res Ther. 2010;12(6):223. DOI: 10.1186/ar3199.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyper- uricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum. 2011 Oct;63(10):3136–41. DOI: 10.1002/art.30520.</mixed-citation><mixed-citation xml:lang="en">Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyper- uricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum. 2011 Oct;63(10):3136–41. DOI: 10.1002/art.30520.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Lu X, Li X, Zhao Y, et al. Contemporary epidemiology of gout and hyperuricemia in community elderly in Beijing. Int J Rheum Dis. 2013 Sep 30. DOI: 10.1111/1756-185X.12156.</mixed-citation><mixed-citation xml:lang="en">Lu X, Li X, Zhao Y, et al. Contemporary epidemiology of gout and hyperuricemia in community elderly in Beijing. Int J Rheum Dis. 2013 Sep 30. DOI: 10.1111/1756-185X.12156.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Silva L, Miguel ED, Peiteado D, et al. Compliance in gout patients. Acta Reumatol Port. 2010;35(5):466–74.</mixed-citation><mixed-citation xml:lang="en">Silva L, Miguel ED, Peiteado D, et al. Compliance in gout patients. Acta Reumatol Port. 2010;35(5):466–74.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Schlesinger N, Thiele RG. The pathogenesis of bone erosions in gouty arthritis. Ann Rheum Dis. 2010;69(11):1907–12. DOI: 10.1136/ard.2010.128454.</mixed-citation><mixed-citation xml:lang="en">Schlesinger N, Thiele RG. The pathogenesis of bone erosions in gouty arthritis. Ann Rheum Dis. 2010;69(11):1907–12. DOI: 10.1136/ard.2010.128454.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bruce SP, Fugit RV. Breaking the chain of gout: pharmacist strate- gies to improve patient outcomes in gout and hyperuricemia.</mixed-citation><mixed-citation xml:lang="en">Bruce SP, Fugit RV. Breaking the chain of gout: pharmacist strate- gies to improve patient outcomes in gout and hyperuricemia.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">A case-based monograph focusing on gout and hyperuricemia for pharmacists. A continuing pharmacy education activity.</mixed-citation><mixed-citation xml:lang="en">A case-based monograph focusing on gout and hyperuricemia for pharmacists. A continuing pharmacy education activity.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">U.S. Pharmacist. 2010 Feb;(2):1–12.</mixed-citation><mixed-citation xml:lang="en">U.S. Pharmacist. 2010 Feb;(2):1–12.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Edwards NL, Sunday JS, Forsuthe A, et al. Work productivity loss due</mixed-citation><mixed-citation xml:lang="en">Edwards NL, Sunday JS, Forsuthe A, et al. Work productivity loss due</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">to flares in patient with chronic gout refractory to conventional therapy.</mixed-citation><mixed-citation xml:lang="en">to flares in patient with chronic gout refractory to conventional therapy.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">J Med Econ 2011;14(1):10–5. DOI: 10.3111/13696998.2010.540874.</mixed-citation><mixed-citation xml:lang="en">J Med Econ 2011;14(1):10–5. DOI: 10.3111/13696998.2010.540874.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kim KY, Schumacher HR, Hunsche E, et al. A literature review of</mixed-citation><mixed-citation xml:lang="en">Kim KY, Schumacher HR, Hunsche E, et al. A literature review of</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">the epidemiology and treatment of acute gout. Clin Ther. 2003;(25):1593–617. DOI: http://dx.doi.org/10.1016/S0149- 2918(03)80158-3.</mixed-citation><mixed-citation xml:lang="en">the epidemiology and treatment of acute gout. Clin Ther. 2003;(25):1593–617. DOI: http://dx.doi.org/10.1016/S0149- 2918(03)80158-3.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Елисеев МС, Мукагова МВ, Барскова ВГ. Качество жизни больных подагрой. Современная ревматология. 2011;(4):35–8. [Eliseyev MS, Mukagova MV, Barskova VG. Quality of life of patients with gout. Sovremennaya revmatologiya = Modern Rheumatology. 2011;(4):35–8. (In Russ.)]. DOI: http://dx.doi.org/10.14412/1996-7012-2011-695.</mixed-citation><mixed-citation xml:lang="en">Елисеев МС, Мукагова МВ, Барскова ВГ. Качество жизни больных подагрой. Современная ревматология. 2011;(4):35–8. [Eliseyev MS, Mukagova MV, Barskova VG. Quality of life of patients with gout. Sovremennaya revmatologiya = Modern Rheumatology. 2011;(4):35–8. (In Russ.)]. DOI: http://dx.doi.org/10.14412/1996-7012-2011-695.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Амирджанова ВН, Горячев ДВ, Коршунов НИ и др. Популяци- онные показатели качества жизни по опроснику SF-36 (результа-ты многоцентрового исследования качества жизни «МИРАЖ»). Научно-практическая ревматология. 2008;(1):36–48. [Amirdjanova VN, Goryachev DV, Korshunov NI, et al. Population indicators of quality of life on SF-36 questionnaire (results of multicen- ter research of quality of life «MIRAGE»). Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2008;(1):36–48.</mixed-citation><mixed-citation xml:lang="en">Амирджанова ВН, Горячев ДВ, Коршунов НИ и др. Популяци- онные показатели качества жизни по опроснику SF-36 (результа-ты многоцентрового исследования качества жизни «МИРАЖ»). Научно-практическая ревматология. 2008;(1):36–48. [Amirdjanova VN, Goryachev DV, Korshunov NI, et al. Population indicators of quality of life on SF-36 questionnaire (results of multicen- ter research of quality of life «MIRAGE»). Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2008;(1):36–48.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">(In Russ.)]. DOI: http://dx.doi.org/10.14412/1995-4484-2008-852. 12. Roddy E, Zhang W, Doherty M. Is gout associated with reduced</mixed-citation><mixed-citation xml:lang="en">(In Russ.)]. DOI: http://dx.doi.org/10.14412/1995-4484-2008-852. 12. Roddy E, Zhang W, Doherty M. Is gout associated with reduced</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">quality of life? A case-control study. Rheumatology (Oxford). 2007;46(9):1441–4. DOI: http://dx.doi.org/10.1093/rheumatol- ogy/kem150.</mixed-citation><mixed-citation xml:lang="en">quality of life? A case-control study. Rheumatology (Oxford). 2007;46(9):1441–4. DOI: http://dx.doi.org/10.1093/rheumatol- ogy/kem150.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Khanna PP, Nuki G, Bardin T, et al. Tophi and frequent gout flares are associated with impairments to quality of life, productiv- ity, and increased healthcare resource use: Results from a cross- sectional survey. Health Qual Life Outcomes. 2012;10:117. DOI: 10.1186/1477-7525-10-117.</mixed-citation><mixed-citation xml:lang="en">Khanna PP, Nuki G, Bardin T, et al. Tophi and frequent gout flares are associated with impairments to quality of life, productiv- ity, and increased healthcare resource use: Results from a cross- sectional survey. Health Qual Life Outcomes. 2012;10:117. DOI: 10.1186/1477-7525-10-117.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Khanna D, Sarkin AJ, Khanna PP, et al. Minimally important dif- ferences of the gout impact scale in a randomized controlled trial. Rheumatology (Oxford). 2011;50(7):1331–6. DOI: 10.1093/rheumatology/ker023. Epub 2011 Mar 3.</mixed-citation><mixed-citation xml:lang="en">Khanna D, Sarkin AJ, Khanna PP, et al. Minimally important dif- ferences of the gout impact scale in a randomized controlled trial. Rheumatology (Oxford). 2011;50(7):1331–6. DOI: 10.1093/rheumatology/ker023. Epub 2011 Mar 3.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Singh JA, Strand V. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisa- tion in US veterans. Ann Rheum Dis. 2008;67(9):1310–6. DOI: 10.1136/ard.2007.081604.</mixed-citation><mixed-citation xml:lang="en">Singh JA, Strand V. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisa- tion in US veterans. Ann Rheum Dis. 2008;67(9):1310–6. DOI: 10.1136/ard.2007.081604.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Chandratre P, Roddy E, Clarson L, et al. Health-related quality of life in gout: a systematic review. Rheumatology (Oxford). 2013;52(11):2031–40. DOI: 10.1093/rheumatology/ket265.</mixed-citation><mixed-citation xml:lang="en">Chandratre P, Roddy E, Clarson L, et al. Health-related quality of life in gout: a systematic review. Rheumatology (Oxford). 2013;52(11):2031–40. DOI: 10.1093/rheumatology/ket265.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Schumacher HR, Taylor W, Edwards L, et al. Outcome domains for studies of acute and chronic gout. J Rheumatol. 2009;36(10):2342–5. DOI: 10.3899/jrheum.090370.</mixed-citation><mixed-citation xml:lang="en">Schumacher HR, Taylor W, Edwards L, et al. Outcome domains for studies of acute and chronic gout. J Rheumatol. 2009;36(10):2342–5. DOI: 10.3899/jrheum.090370.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Singh J, Taylor WJ, Simon LS, et al. Patient-reported outcomes in chronic gout: a report from OMERACT 10. J Rheumatol. 2011;38(7):1452–7. DOI: 10.3899/jrheum.110271.</mixed-citation><mixed-citation xml:lang="en">Singh J, Taylor WJ, Simon LS, et al. Patient-reported outcomes in chronic gout: a report from OMERACT 10. J Rheumatol. 2011;38(7):1452–7. DOI: 10.3899/jrheum.110271.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Барскова ВГ, Елисеев МС, Денисов ИС и др. Частота метабо- лического синдрома и сопутствующих заболеваний у боль- ных подагрой. Даннные многоцентрового исследования. На- учно-практическая ревматология. 2012;50(6):15–8.</mixed-citation><mixed-citation xml:lang="en">Барскова ВГ, Елисеев МС, Денисов ИС и др. Частота метабо- лического синдрома и сопутствующих заболеваний у боль- ных подагрой. Даннные многоцентрового исследования. На- учно-практическая ревматология. 2012;50(6):15–8.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">[Barskova VG, Eliseyev MS, Denisov IS, et al. The rate of meta- bolic syndrome and comorbidities in patients with gout: data of a multicenter trial. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2012;50(6):15–8. (In Russ.). DOI: http://dx.doi.org/10.14412/1995-4484-2012-1287.</mixed-citation><mixed-citation xml:lang="en">[Barskova VG, Eliseyev MS, Denisov IS, et al. The rate of meta- bolic syndrome and comorbidities in patients with gout: data of a multicenter trial. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2012;50(6):15–8. (In Russ.). DOI: http://dx.doi.org/10.14412/1995-4484-2012-1287.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Scire CA, Manara M, Cimmino MA, et al.; KING Study Collaborators. Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR). Arthritis Res Ther. 2013 Aug 23;15(5):101. DOI: 10.1186/ar4281.</mixed-citation><mixed-citation xml:lang="en">Scire CA, Manara M, Cimmino MA, et al.; KING Study Collaborators. Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR). Arthritis Res Ther. 2013 Aug 23;15(5):101. DOI: 10.1186/ar4281.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Becker MA, Schumacher HR, Benjamin KL, et al.; Gout Natural History Study Group, Sundy JS. Quality of life and disability in patients with treatment-failure gout. J Rheumatol. 2009 May;36(5):1041–8. DOI: 10.3899/jrheum.071229.</mixed-citation><mixed-citation xml:lang="en">Becker MA, Schumacher HR, Benjamin KL, et al.; Gout Natural History Study Group, Sundy JS. Quality of life and disability in patients with treatment-failure gout. J Rheumatol. 2009 May;36(5):1041–8. DOI: 10.3899/jrheum.071229.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Lee SJ, Hirsch JD, Terkeltaub R, et al. Perceptions of disease and health-related quality of life among patients with gout. Rheumatology (Oxford). 2009;48(5):582–6. DOI: 10.1093/rheumatology/kep047.</mixed-citation><mixed-citation xml:lang="en">Lee SJ, Hirsch JD, Terkeltaub R, et al. Perceptions of disease and health-related quality of life among patients with gout. Rheumatology (Oxford). 2009;48(5):582–6. DOI: 10.1093/rheumatology/kep047.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
